Which Antiplatelet Therapy in Patients With Left Ventricular Assist Device and Aspirin Allergy?

F Consolo, L Pozzi, G Sferrazza, P Della Valle, A D'Angelo, MJ Slepian, F Pappalardo

Research output: Contribution to journalArticlepeer-review

Abstract

In patients with left ventricular assist device support and aspirin allergy, the choice of effective antiplatelet strategy remains a challenge. We compared the antithrombotic effect of clopidogrel vs ticagrelor in an LVAD patient with aspirin allergy by using a modified protocol of the thrombin generation test, accounting selectively for the platelet contribution on thrombin generation. Our results demonstrate enhanced antithrombotic efficacy offered by ticagrelor. Consistent with experimental results, the patient has passed more than 300 days without thromboembolic complications. This study provides additional mechanistic rationale supporting clinical evidence and opens the perspective to identify individual poor responsiveness to drugs by specifically evaluating drug-mediated platelet function. © 2018 The Society of Thoracic Surgeons
Original languageEnglish
Pages (from-to)e47-e49
JournalAnnals of Thoracic Surgery
Volume105
Issue number2
DOIs
Publication statusPublished - 2018

Fingerprint

Dive into the research topics of 'Which Antiplatelet Therapy in Patients With Left Ventricular Assist Device and Aspirin Allergy?'. Together they form a unique fingerprint.

Cite this